SEC 13F Intelligence

Assenagon Asset Management S.A. / PFE

Assenagon Asset Management S.A.’s Pfizer Inc Position

Does Assenagon Asset Management S.A. own Pfizer Inc (PFE)? Yes11.90M shares worth $287M (+0.36% of its 13F portfolio) as of Q2 2026, up from 6.07M shares the prior filed quarter.

Position Value
$287M
Q2 2026
Shares
11.90M
% of Portfolio
+0.36%
Quarters Held
29
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $76MQ4 ’18Q1 ’19: $849,000Q2 ’19: $142MQ3 ’19: $269,000Q4 ’19: $3MQ4 ’19Q2 ’20: $233,000Q3 ’20: $28MQ4 ’20: $34MQ2 ’21: $129MQ2 ’21Q3 ’21: $162MQ4 ’21: $222MQ1 ’22: $238MQ2 ’22: $103MQ2 ’22Q3 ’22: $543MQ4 ’22: $163,113Q1 ’23: $280MQ2 ’23: $113MQ2 ’23Q3 ’23: $139MQ4 ’23: $183MQ1 ’24: $166MQ2 ’24: $133MQ2 ’24Q3 ’24: $150MQ4 ’24: $65MQ1 ’25: $255MQ2 ’25: $120MQ2 ’25Q3 ’25: $221MQ4 ’25: $51MQ1 ’26: $171MQ2 ’26: $287MQ2 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202611.90M$287M+0.36%
Q1 20266.07M$171M+0.26%
Q4 20252.06M$51M+0.07%
Q3 20258.69M$221M+0.30%
Q2 20254.97M$120M+0.18%
Q1 202510.05M$255M+0.42%
Q4 20242.47M$65M+0.11%
Q3 20245.17M$150M+0.28%
Q2 20244.77M$133M+0.30%
Q1 20245.97M$166M+0.39%
Q4 20236.37M$183M+0.49%
Q3 20234.18M$139M+0.43%
Q2 20233.07M$113M+0.39%
Q1 20236.87M$280M+1.00%
Q4 20223.18M$163,113+0.59%
Q3 202212.40M$543M+2.08%
Q2 20221.97M$103M+0.38%
Q1 20224.60M$238M+0.66%
Q4 20213.77M$222M+0.64%
Q3 20213.76M$162M+0.52%
Q2 20213.29M$129M+0.44%
Q4 2020933.1K$34M+0.15%
Q3 2020765.3K$28M+0.16%
Q2 20207.1K$233,0000.00%
Q4 201982.5K$3M+0.02%
Q3 20197.5K$269,0000.00%
Q2 20193.29M$142M+1.07%
Q1 201920.0K$849,000+0.01%
Q4 20181.73M$76M+0.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of PFE.